SCHEMBL1664531

SCHEMBL1664531

Cc1c[nH]c(C(=O)Nc2ccc(C(=O)c3ccc(Nc4ccc(N5CCC(O)CC5)cc4)cc3)cc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.49
RAB9A P51151 7/20 0.49
NPC1 O15118 6/20 0.49
KMT2A Q03164 6/20 0.49
KDM4E B2RXH2 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
MEN1 O00255 3/20 0.49
MCL1 Q07820 3/20 0.49
LMNA P02545 3/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
TP53 P04637 1/20 0.47
PKM P14618 1/20 0.47
MAPK1 P28482 1/20 0.47
ALDH1A1 P00352 4/20 0.46
HPGD P15428 2/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
USP2 O75604 2/20 0.46
GFER P55789 1/20 0.44
GLA P06280 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1664532 0.96 RAB9A (0.54) MAPTRAB9ANPC1KMT2AKDM4E
SCHEMBL1665250 0.83 RAB9A (0.53) MAPTRAB9ANPC1KMT2AKDM4E
SCHEMBL1664961 0.83 NPC1 (0.65) MAPTRAB9ANPC1KMT2AKDM4E
SCHEMBL1664469 0.82 RAB9A (0.58) MAPTRAB9ANPC1KMT2AKDM4E
SCHEMBL8769706 0.82 RAB9A (0.58) MAPTRAB9ANPC1KMT2AKDM4E
SCHEMBL1665067 0.82 MAPK10 (0.42) MAPTRAB9ANPC1KMT2AKDM4E
SCHEMBL1664758 0.81 MAPT (0.46) MAPTRAB9ANPC1KMT2AKDM4E
SCHEMBL1664358 0.81 NPC1 (0.46) MAPTRAB9ANPC1KMT2AKDM4E
SCHEMBL1664207 0.81 MAPT (0.45) MAPTRAB9ANPC1KMT2AKDM4E
SCHEMBL1665061 0.81 MAPT (0.48) MAPTRAB9ANPC1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed